Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine
OMICS: A Journal of Integrative Biology · 2023
DOI: 10.1089/omi.2023.0092 ↗Kurz gefasst
Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, 2023. Verfasst von Mansoor Ali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Berberine, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
MicroRNA aberrations including that of miR-24-2 have been reported in various cancers. However, the target genes for miR-24-2 are yet to be identified and validated in invasive breast cancer and the triple-negative breast cancer (TNBC). Using in silico approaches and gene expression analyses, we identified and validated the target genes of miR-24-2 in invasive breast cancer, majority of which were TNBC. We studied the translational potential of these target genes using berberine in a TNBC cell line. Differentially expressed genes targeted by miR-24-2 were identified and analyzed for their survival effects using the The Cancer Genome Atlas-Breast Invasive Carcinoma (-BRCA) samples. Furthermore, we carried out protein–protein interaction, Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, gene expression, and Kaplan-Meier survival analyses using common targets of miR-24-2 in invasive breast cancer/TNBC. We identified 11 biomarker candidate genes as crucial targets of miR-24-2. The survival of breast cancer patients was significantly associated with the low expressions of nine genes, including RACGAP1 , KIAA1199 , TIMM17A , LYRM7 , IL1R1 , SLC1A3 , DTX4 , L1CAM , and SAP30-like ( SAP30L ), and high expressions of two genes, SOD2 and HLA-DQB2 . These in silico findings were validated by overexpressing miR-24-2 and assessing the expression pattern of these target genes in the TNBC MDA-MB-231 cells. miR-24-2 overexpression inhibited (by 20%; p < 0.001) cell proliferation and sensitized the anticancer effect of berberine. In all, this study reports on the novel target genes of miR-24-2 in invasive breast cancer/TNBC, and that miR-24-2 sensitizes MDA-MB-231 cells to berberine. These data lend evidence for the translational potentials of miR-24-2 for invasive breast cancer diagnostic and therapeutic innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
- Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, Colorado, USA.
ORCID-Profile: Rana P Singh
Zitieren
APA
Ali, M., Bamezai, R. N. K., & Singh, R. P. (2023). Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2023.0092
Vancouver
Ali M, Bamezai RNK, Singh RP. Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. OMICS: A Journal of Integrative Biology. 2023. doi:10.1089/omi.2023.0092
BibTeX
@article{Ali2023,
author = {Ali, Mansoor and Bamezai, Rameshwar N K and Singh, Rana P},
title = {Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine},
journal = {OMICS: A Journal of Integrative Biology},
year = {2023},
doi = {10.1089/omi.2023.0092}
}
EUVIMED